• Home
  • About Us
    • Who we are
    • Our Early History
    • Technology
    • Target Markets
      • Venous and pressure ulcers
      • Other Applications
    • Business Model
    • Licensing
    • Clinical Trial
    • Publications & Presentations
    • Company Milestones
    • Focus
  • The Company
    • Board & Management
      • Paul Wright
      • Mark Richardson
      • George Baumanis
      • Stuart Usher
  • Advisory Team
    • Intellectual Property
      • Vaughan Barlow
      • Tom Boyce
      • Audrey Yap
      • Yvette Flanigan
    • Principal Advisor
      • Mark Woolley
    • Medical and Scientific Advisory Committee
      • James Fries
      • Michael Woodward
    • Scientific
      • Richard Lipscombe
    • Clinical
      • Geoffrey Mitchell
    • Health Economics
      • Nicholas Graves
  • Media
  • Links
  • Members Log in
  • Contact Us

News Headlines

> 18/01/10
Phoenix Eagle commences clinical trial.


> 01/12/09
OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.

The Phoenix Eagle Board & Management

Mark Richardson, Co-Founder and Managing Director

Board & Management - Mark Richardson, Co-Founder and Managing Director

Mark was born in New South Wales in 1950 and was brought up in Central Africa. He holds the degrees of B.A. and M.A. in Geology from Oxford University, a Graduate Diploma in Mining and Metallurgy from the University of New South Wales and a Master of Industrial Relations from the University of Western Australia.

Prior to co-founding Phoenix Eagle, Mark worked in the mining industry, for a short time as a geologist and then as a mining engineer. He has managed a number of mining operations in Africa, Australia and China and for several years was the managing director of two related mining companies listed on the Australian Securities Exchange.

The Phoenix Eagle Company Pty Ltd website is proudly maintained by NetBiz Enterprises.